Expected US Company Earnings on Monday, September 23rd, 2024

Stock Information for Entero Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Entero Therapeutics Inc.

Creatd, Inc. Completes 2024 PCAOB Audit, Achieving Two Years of Audited Financials and Clearing Path Toward SEC Re-Registration and National Exchange Uplisting
Creatd, Inc. Publishes Q1 2025 Financial Report Highlighting a $7.9M Improvement in Net Equity
Creatd, Inc. to Acquire Strategic Stakes in PCG Advisory Inc., and Related Affiliates in $2.3 Million All-Stock Transaction
Creatd, Inc. to Acquire Air Charter Advisors in $3-$6 Million Stock Deal, Further Strengthening Its Aviation Portfolio Following the $8.3 Million Flyte Acquisition
Creatd Subsidiary Flyte Launches AI-Powered Travel Booking Platform
Creatd, Inc. Finalizes $8.3M Flewber Acquisition, Unveils AI-Powered Flyte to Transform the Private Air Travel Industry
Creatd, Inc. to Acquire Flewber in $7.5 Million Deal, Positioning Creatd at the Forefront of the $28.5 Billion Regional Air Mobility Sector
Creatd Completes Audit and Submits Application for OTCQB Reinstatement

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.